Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure

Abstract Background Studies focusing on sex differences in circulating proteins in patients with heart failure with reduced ejection fraction (HFrEF) are scarce. Insight into sex-specific cardiovascular protein profiles and their associations with the risk of adverse outcomes may contribute to a bet...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Biology of Sex Differences
المؤلفون الرئيسيون:	Marie de Bakker, Teun B. Petersen, K. Martijn Akkerhuis, Magdalena Harakalova, Victor A. Umans, Tjeerd Germans, Kadir Caliskan, Peter D. Katsikis, Peter J. van der Spek, Navin Suthahar, Rudolf A. de Boer, Dimitris Rizopoulos, Folkert W. Asselbergs, Eric Boersma, Isabella Kardys
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2023-05-01
الموضوعات:	Sex differences Proteomics Heart failure HFrEF
الوصول للمادة أونلاين:	https://doi.org/10.1186/s13293-023-00516-9

مواد مشابهة

Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure
حسب: Marie deBakker, وآخرون
منشور في: (2024-02-01)

Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum
حسب: Karolina Andrzejczyk, وآخرون
منشور في: (2024-06-01)

Proteomic biomarkers and biological pathways associated with atrial fibrillation in heart failure patients with reduced ejection fraction
حسب: Teun B. Petersen, MSc, وآخرون
منشور في: (2025-09-01)

Heart failure with improved ejection fraction: patient characteristics, clinical outcomes and predictors for improvement
حسب: Amitai Segev, وآخرون
منشور في: (2024-07-01)

Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk factors
حسب: Akshat Agrawal, وآخرون
منشور في: (2025-07-01)

Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index
حسب: Paolo Tolomeo, وآخرون
منشور في: (2022-06-01)

The Sub-Analysis of HFmrEF and HFrEF Group in CORE-HF Registry : When being Good is Not Enough
حسب: Irnizarifka Irnizarifka, وآخرون
منشور في: (2023-10-01)

A Comprehensive Profile of Heart Failure Patients Across Ejection Fraction Subtypes: Insights from a Single-Center Retrospective Cohort Study
حسب: Austėja Kaunaitė, وآخرون
منشور في: (2025-08-01)

Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia
حسب: Kengo Ayabe, وآخرون
منشور في: (2024-10-01)

Glycosphingolipids in Cardiovascular Disease: Insights from Molecular Mechanisms and Heart Failure Models
حسب: Sarah Huang, وآخرون
منشور في: (2024-10-01)

Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
حسب: Stephanie J. Rowe, BBiomed, MD, وآخرون
منشور في: (2025-01-01)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
حسب: Verena Tscholl, وآخرون
منشور في: (2021-08-01)

Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
حسب: Jenni Huusko, وآخرون
منشور في: (2019-08-01)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis
حسب: Arjun K. Pandey, وآخرون
منشور في: (2022-04-01)

T1 and T2 mapping to detect chronic inflammation in cardiac magnetic resonance imaging in heart failure with reduced ejection fraction
حسب: Tilman Emrich, وآخرون
منشور في: (2020-10-01)

Heart failure: an update from the last years and a look at the near future
حسب: Mauro Riccardi, وآخرون
منشور في: (2022-12-01)

Proteomic Associations of Adverse Outcomes in Human Heart Failure
حسب: Marie‐Joe Dib, وآخرون
منشور في: (2024-03-01)

Total-Arterial Revascularization Is Superior in Heart Failure Patients with Reduced Ejection Fraction—A Propensity Score Matched Retrospective Multicenter Analysis
حسب: Christian Jörg Rustenbach, وآخرون
منشور في: (2025-09-01)

The use of sacubitril/valsartan in different forms of heart failure
حسب: Mohammad Abumayyaleh, وآخرون
منشور في: (2025-06-01)

Intravenous iron in heart failure: still no prognostic impact, but questions remain
حسب: Ibrahim El-Battrawy, وآخرون
منشور في: (2025-08-01)

Association between blood eosinophil levels and prognosis in critically ill patients with different heart failure phenotypes
حسب: Chengjian Guan, وآخرون
منشور في: (2025-02-01)

Influence of Obesity on Short-Term Surgical Outcomes in HFrEF Patients Undergoing CABG: A Retrospective Multicenter Study
حسب: Christian Jörg Rustenbach, وآخرون
منشور في: (2024-02-01)

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
حسب: Norman Mangner, وآخرون
منشور في: (2023-10-01)

Phenotyping patients with chronic obstructive pulmonary disease and heart failure
حسب: Peter Moritz Becher, وآخرون
منشور في: (2025-04-01)

Machine Learning-Driven Prediction of One-Year Readmission in HFrEF Patients: The Key Role of Inflammation
حسب: Ma F, وآخرون
منشور في: (2025-07-01)

Cardiac Contractility Modulation in Patients with Heart Failure with Reduced Left Ventricular Ejection Fraction
حسب: Francesco Giallauria, وآخرون
منشور في: (2021-03-01)

Treatment patterns of patients with worsening heart failure with reduced ejection fraction
حسب: Stephen J. Greene, وآخرون
منشور في: (2024-08-01)

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
حسب: Gregor Poglajen, وآخرون
منشور في: (2020-07-01)

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer
حسب: Henrike Arfsten, وآخرون
منشور في: (2021-10-01)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
حسب: Dan Liu, وآخرون
منشور في: (2023-04-01)

Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis
حسب: Wanqian Yu, وآخرون
منشور في: (2025-07-01)

EVOLUTION‐HF DEallEF: A non‐interventional study of patients with heart failure initiated on dapagliflozin: study design
حسب: Matthias Paul, وآخرون
منشور في: (2025-08-01)

Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis
حسب: Wanqian Yu, وآخرون
منشور في: (2025-05-01)

Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First‐in‐Human, Randomized, Single‐Blind, Placebo‐Controlled Study
حسب: Kathleen Connolly, وآخرون
منشور في: (2024-08-01)

D‐dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes
حسب: Liyan Huang, وآخرون
منشور في: (2022-10-01)

Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide
حسب: Zsombor I. Hegedűs, وآخرون
منشور في: (2025-06-01)

Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology
حسب: Jack O. Garnham, وآخرون
منشور في: (2020-04-01)

Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings
حسب: Reza Parvan, وآخرون
منشور في: (2025-08-01)

Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON‐HF Proteomic Substudy
حسب: Natasha L. Patel‐Murray, وآخرون
منشور في: (2024-07-01)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
حسب: Jenni Huusko, وآخرون
منشور في: (2020-06-01)